PINCER BIOTECH’s vision is to treat the untreatable
CEO, Dr Charlotte Dyring
Who we are
We are a privately held, preclinical biotech company, founded in 2019 and located in Aarhus, Denmark.
Our mission is to develop a targeted, safe and effective cure for biomedical implant-associated infections reducing the risk of antimicrobial resistance and saving lives.
We do so by pioneering scientific breakthroughs in close collaboration with leading experts in infectious diseases and vascular implants, and top scientists from industry and academia.